Kite, HiFiBiO Therapeutics partner to discover novel targets and antibodies against AML

HiFiBiO will use its proprietary technology platforms to identify novel AML targets and anti-AML specific antibodies for Kite’s use in cell therapies. (Credit: PublicDomainPictures from Pixabay)